BAX
Price
$24.59
Change
+$0.19 (+0.78%)
Updated
Aug 29, 03:50 PM (EDT)
Capitalization
12.53B
62 days until earnings call
LUNG
Price
$1.71
Change
-$0.05 (-2.84%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
71.71M
61 days until earnings call
Interact to see
Advertisement

BAX vs LUNG

Header iconBAX vs LUNG Comparison
Open Charts BAX vs LUNGBanner chart's image
Baxter International
Price$24.59
Change+$0.19 (+0.78%)
Volume$425
Capitalization12.53B
Pulmonx
Price$1.71
Change-$0.05 (-2.84%)
Volume$7.45K
Capitalization71.71M
BAX vs LUNG Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. LUNG commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and LUNG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (BAX: $24.40 vs. LUNG: $1.76)
Brand notoriety: BAX and LUNG are both not notable
BAX represents the Pharmaceuticals: Other, while LUNG is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 62% vs. LUNG: 124%
Market capitalization -- BAX: $12.53B vs. LUNG: $71.71M
BAX [@Pharmaceuticals: Other] is valued at $12.53B. LUNG’s [@Medical/Nursing Services] market capitalization is $71.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 1 FA rating(s) are green whileLUNG’s FA Score has 1 green FA rating(s).

  • BAX’s FA Score: 1 green, 4 red.
  • LUNG’s FA Score: 1 green, 4 red.
According to our system of comparison, BAX is a better buy in the long-term than LUNG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while LUNG’s TA Score has 4 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 4 bearish.
  • LUNG’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BAX is a better buy in the short-term than LUNG.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а +2.31% price change this week, while LUNG (@Medical/Nursing Services) price change was +15.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.47%. For the same industry, the average monthly price growth was +5.74%, and the average quarterly price growth was +15.16%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.88%. For the same industry, the average monthly price growth was +6.74%, and the average quarterly price growth was +10.13%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

LUNG is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+0.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($12.5B) has a higher market cap than LUNG($71.7M). BAX YTD gains are higher at: -15.448 vs. LUNG (-74.080). BAX has higher annual earnings (EBITDA): 1.04B vs. LUNG (-51.84M). BAX has more cash in the bank: 1.69B vs. LUNG (84.2M). LUNG has less debt than BAX: LUNG (56.8M) vs BAX (9.73B). BAX has higher revenues than LUNG: BAX (10.9B) vs LUNG (90.5M).
BAXLUNGBAX / LUNG
Capitalization12.5B71.7M17,434%
EBITDA1.04B-51.84M-1,997%
Gain YTD-15.448-74.08021%
P/E Ratio87.85N/A-
Revenue10.9B90.5M12,044%
Total Cash1.69B84.2M2,002%
Total Debt9.73B56.8M17,121%
FUNDAMENTALS RATINGS
BAX: Fundamental Ratings
BAX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BAXLUNG
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
51%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
61%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCHT7.30N/A
N/A
Mauch Chunk Trust Financial Corp.
IARGF12.00N/A
N/A
I A R Systems Group AB
FCELB301.99-6.13
-1.99%
FuelCell Energy, Inc.
EQGPF65.54-7.53
-10.31%
EQB Inc
UNCHF6.17-0.73
-10.58%
Unicharm Corp.

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
-0.53%
ALGN - BAX
68%
Closely correlated
-0.60%
LUNG - BAX
53%
Loosely correlated
-5.38%
STE - BAX
51%
Loosely correlated
-1.69%
SYK - BAX
51%
Loosely correlated
-0.89%
SOLV - BAX
50%
Loosely correlated
-0.32%
More